EMCYT

This brand name is authorized in Mexico, United States

Active ingredients

The drug EMCYT contains one active pharmaceutical ingredient (API):

1 Estramustine UNII 75F375MT2N - ESTRAMUSTINE PHOSPHATE SODIUM

Estramustine is a chemical compound of oestradiol and nitrogen mustard. It is effective in the treatment of advanced prostatic carcinoma. Estramustine has a dual mode of action. The intact molecule acts as an anti-miotic agent; after hydrolysis of the carbamate ester, the metabolites act to bridge the released oestrogens and exert an anti-gonadotrophic effect. Read about Estramustine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EMCYT Capsule	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01XX11	Estramustine	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XX Other antineoplastic agents
Discover more medicines within L01XX11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 061M96
Country: US	FDA, National Drug Code	Identifier(s): 0013-0132